Thank you for your interest in the Hematology/Medical Oncology Fellowship Program at the Icahn School of Medicine at Mount Sinai and Tisch Cancer Institute. It is a very exciting time to train and work within the Division and Tisch Cancer Institute given the recruitment of talented faculty, continued growth of clinical programs and recent prestigious selection as the 69th National Cancer Institute (NCI)-designated Cancer Center. The Hematology/Medical Oncology Fellowship Program is an ACGME accredited training program designed to provide a robust clinical exposure in all aspects of Hematology/Medical Oncology as well as dedicated research time with guided mentorship and career development for a future academic career.
As of July 1, 2017, the Mount Sinai Beth Israel and Mount Sinai Hospital programs merged to form a single fellowship within the Mount Sinai Health System. Our combined Hematology/Medical Oncology training program is 36 months in duration, of which 18 months are dedicated to providing a broad exposure to the clinical practice of our field through both, inpatient and outpatient rotations. These include the following inpatient rotations: Hematology consults, Solid Tumor consults, Leukemia, Multiple Myeloma/Lymphoma, Palliative Care consults and BMT at Mount Sinai Hospital; Inpatient Hematology/Oncology Consults and Palliative Care consults at Mount Sinai Beth Israel. During outpatient rotations, fellows select to rotate through outpatient disease-focused practices in the Ruttenberg Treatment & Dubin Breast Centers (MSH), Mount Sinai Downtown Union Square & Chelsea (MSBI) as well as Mount Sinai West/St. Luke’s (MSW). Clinical rotations have been formulated to provide maximal educational content and to promote scholarly discussion and debate among fellows, faculty and allied health professionals
The second 18 months of the fellowship program is devoted to protected, mentored research time. During this time, fellows choose a mentor and are guided through the process of developing a research project. Our expectation is that fellow research projects will result in training grants and other funding to allow trainees to further develop their interests and foster careers as academic leaders. Fellows are able to choose from a broad range of faculty mentors focusing on a diverse array of research (basic science, translational, clinical, outcomes, quality improvement or medical education) within the Division of Hematology/Medical Oncology, Tisch Cancer Institute or other research institutes within The Icahn School of Medicine at Mount Sinai. To further guide fellows and their faculty mentors, Fellow Research Guidelines have been developed to outline expectations between mentors and mentees, provide timelines for research plans, progress reports and publications. Opportunities for advanced training in clinical research through the Masters in Clinical Research (MSCR) or Masters in Public Health (MPH) through the Graduate School for Biomedical Science at the Icahn School of Medicine are also available.
Throughout the three-year fellowship program, fellows participate in a comprehensive educational curriculum, which complements their clinical and research experiences. The curriculum includes weekly case conferences, academic half-day core curriculum, disease-focused tumor boards, journal clubs, workshops and weekly Grand Rounds and research seminars.
The field of Hematology/Medical Oncology is rapidly evolving with the development of novel therapeutics, immunotherapy and personalized medicine. Our fellowship program is poised to continue to grow and flourish as we enter this exciting new era!
Adriana K. Malone, MD
Director, Hematology and Medical Oncology Fellowship Program
Director, BMT Fellowship Program
Associate Professor of Medicine, Hematology and Medical Oncology